We are live on ! Find out more
STIM icon

Neuronetics

59 hedge funds and large institutions have $23.1M invested in Neuronetics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 12

5.45% less ownership

Funds ownership: 70.95%65.51% (-5.4%)

13% less funds holding

Funds holding: 6859 (-9)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

42% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 19

61% less capital invested

Capital invested by funds: $59.3M → $23.1M (-$36.2M)

Holders
59
Holders Change
-9
Holders Change %
-13.24%
% of All Funds
1.3%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
11
Increased
25
Reduced
12
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
76
AllianceBernstein
Tennessee
-$46K -10,200 Closed
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
-$7K -1,648 Closed
FMT
78
First Mercantile Trust
Tennessee
-$4K -829 Closed

STIM Hedge Fund Activity: Q1 2020 in Review

59 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q1 2020, worth a combined $23.1M — down 61% from $59.3M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of STIM and 11 opened new positions — a net loss of 8 holders — while 12 trimmed existing stakes and 25 added.

The largest buyer was Deerfield Management, adding an estimated $1.56M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $3.81M sold.

  • 59 institutional investors held Neuronetics (STIM) as of Q1 2020, down from 68 in Q4 2019.
  • Funds reported $23.1M of Neuronetics stock for Q1 2020, down 61% quarter-over-quarter.
  • 11 funds opened new Neuronetics positions in Q1 2020 and 19 closed out, a net change of -8 holders.
  • The largest Neuronetics buyer in Q1 2020 was Deerfield Management, an estimated $1.56M added.
  • The largest Neuronetics seller in Q1 2020 was Capital Research Global Investors, an estimated $3.81M sold.

Based on aggregated 13F filings for Q1 2020.